Clover Health Secures $160 Million Series C Funding to Advance Medicare Advantage with Big Data and Preventive Care

Recently, Clover Health, a health insurance company headquartered in San Francisco, secured $160 million in its latest Series C financing round. By integrating insurance with big data, Clover Health aims to identify potentially high-risk patients through database searches, thereby reducing healthcare costs incurred during patient treatment via disease prevention and delivering a better medical experience for users. The lead investor in this round was Greenoaks Capital.Sequoia Capital, Social Capital and Wildcat Ventures, AME Cloud Ventures, Casdin Capital, Nexus Ventures, Refactor Capital, and Spark Capital. To date, Clover Health has raised a total of approximately $285 million.

The company leverages databases to identify high-risk patient populations, enabling preventive care and reducing medical costs.

In 2012, Clover Health was founded in San Francisco, USA. The company aims to identify potential health risks among patients through precise medical big data analytics. By collecting users’ medical histories from their past health insurance claims and matching them with models established in its database, the team identifies high-risk populations and helps them improve their health status. This enables proactive health interventions before diseases occur, thereby reducing the costs incurred by the company in its health insurance programs.

Clover Health’s target customers are primarily older adults and individuals with lower income levels. After database analytics generate a list of individuals with a higher likelihood of illness, the company willArranging for caregivers to conduct regular home-based health check-ups, or reminding patients to resume treatment if they have interrupted a specific therapy, helps patients avoid hospitalization. This measure saves the company an average of $10,000 per patient in healthcare costs. Furthermore, by implementing preventive care measures, Clover Health has reduced patient hospitalization rates. The company’s insurance service is currently available in several cities in New Jersey, including Jersey City. Data from the first half of 2015 shows that, compared to other populations in New Jersey, users enrolled in Clover Health’s insurance plan had a 50% lower hospitalization rate and a 34% lower readmission rate. Additionally, if a patient is hospitalized, Clover Health dispatches professional caregivers to provide home-based services after surgery to ensure the patient takes the appropriate postoperative medications.

The project aims to improve users' health status.

Kris Gale, the company’s CTO, stated, “Our core philosophy is to leverage data and software to build a clinical profile database for users, identify the gap between treatment approaches and actual health risks, and bridge this gap through healthcare services. We have a small team that delivers targeted health interventions toward specific goals, thereby improving users’ health outcomes. This holds positive significance for us.”

The primary reasons why Clover Health was able to secure substantial financing are as follows:

1. Transforming Passive Treatment into Active Prevention. Clover Health leverages big data technology to identify high-risk populations and implement preventive measures before disease onset, thereby avoiding the physical suffering and substantial medical costs associated with serious illnesses for patients, thus truly realizing the concept of “preventive healthcare.”

2. Precise targeting of the user base and accurate identification of industry pain points. Elderly individuals and patients with lower incomes may incur higher out-of-pocket costs during the diagnosis and treatment of serious illnesses.

When discussing competitors, Kris Gale stated that Clover Health’s primary rivals are traditional Medicare Advantage insurers, such as UnitedHealthcare. These traditional insurers still hold larger market shares and can collectively mobilize greater resources to collect and process data in similar ways. However, unlike Clover Health, these companies do not gather user information to the same extent, leaving Clover Health with an opportunity to establish a firm foothold in this market.

Clover Health Financing Status

The company secured a $100 million investment from First Round Capital in September 2015 and completed a $35 million Series B financing round in December of the same year, led by Sequoia Capital. On May 20, 2016, Clover Health announced the completion of a $160 million Series C financing round, with Greenoaks Capital as the investor.

                                              Clover Health Financing Overview

Clover Health Team

Vivek Garipalli, Co-Founder and CEO of Clover Health, graduated from Emory University with a degree in Business Administration and has devoted many years to the field of big data models in healthcare., he previously worked in the mergers and acquisitions division of Credit Suisse First Boston and at JPMorgan Partners Private Equity, and served at The Blackstone Group. In his early career, Vivek Garipalli

An active investor in the healthcare and medical sector, with a portfolio that includes AAVP Biosystems, Care at Hand, Docphin, LiveProcess, Bell Biosystems, and Doctors Evidence. The Co-founder and CTO formerly served as Vice President at Yammer and has many years of experience in software engineering.

From left to right in the above image are CEO Vivek Garipalli and CTO Kris Gale.